Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nortran Pharmaceutical -NRT.V -- Ignore unavailable to you. Want to Upgrade?

To: Carter Berezay who wrote (379)	4/8/1998 6:17:00 PM
From: Donald Smelser	Read Replies (1) \| Respond to of 1185

Here is the press release for NRT Wednesday April 8, 5:48 pm Eastern Time Company Press Release SOURCE: Nortran Pharmaceuticals Inc. Nortran Pharmaceuticals Inc. Announces Negotiations Continuing Regarding Collaboration Or Licensing Agreement VANCOUVER, April 8 /CNW-PRN/ - Nortran Pharmaceuticals Inc. (VSE: NRT, NASD BB: NTRDF) reports that, further to its news release of March 31, 1998, negotiations are continuing regarding a collaboration or licensing agreement covering certain of its intellectual property. As previously stated, there is no assurance that either current negotiations or discussions with any other parties will result in an agreement. A further news release will be issued if and when an agreement is reached Nortran is a drug discovery company whose technology foundation is a synergy of pathology targeting and molecular targeting of ion channels. The Company's current drugs in development are targeted to prevent death due to heart attack and to suppress severe pain. ON BEHALF OF THE BOARD Allen I. Bain, Ph.D. President THE VANCOUVER STOCK EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS NEWS RELEASE. SOURCE: Nortran Pharmaceuticals Inc. More Quotes and News: Nortran Pharmaceuticals Inc (OTC BB:NTRDF - news; Vancouver:NRT.V - news) Related News Categories: medical/pharmaceutical